全文获取类型
收费全文 | 9421篇 |
免费 | 551篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 91篇 |
儿科学 | 217篇 |
妇产科学 | 258篇 |
基础医学 | 1305篇 |
口腔科学 | 223篇 |
临床医学 | 965篇 |
内科学 | 2197篇 |
皮肤病学 | 96篇 |
神经病学 | 787篇 |
特种医学 | 295篇 |
外科学 | 1125篇 |
综合类 | 114篇 |
一般理论 | 13篇 |
预防医学 | 779篇 |
眼科学 | 180篇 |
药学 | 750篇 |
中国医学 | 5篇 |
肿瘤学 | 613篇 |
出版年
2023年 | 56篇 |
2022年 | 82篇 |
2021年 | 170篇 |
2020年 | 141篇 |
2019年 | 159篇 |
2018年 | 186篇 |
2017年 | 148篇 |
2016年 | 124篇 |
2015年 | 215篇 |
2014年 | 275篇 |
2013年 | 442篇 |
2012年 | 686篇 |
2011年 | 695篇 |
2010年 | 357篇 |
2009年 | 318篇 |
2008年 | 595篇 |
2007年 | 663篇 |
2006年 | 654篇 |
2005年 | 624篇 |
2004年 | 591篇 |
2003年 | 533篇 |
2002年 | 575篇 |
2001年 | 98篇 |
2000年 | 95篇 |
1999年 | 126篇 |
1998年 | 109篇 |
1997年 | 101篇 |
1996年 | 86篇 |
1995年 | 89篇 |
1994年 | 67篇 |
1993年 | 65篇 |
1992年 | 69篇 |
1991年 | 77篇 |
1990年 | 57篇 |
1989年 | 52篇 |
1988年 | 43篇 |
1987年 | 39篇 |
1986年 | 52篇 |
1985年 | 46篇 |
1984年 | 41篇 |
1983年 | 35篇 |
1982年 | 58篇 |
1981年 | 30篇 |
1980年 | 28篇 |
1979年 | 29篇 |
1978年 | 26篇 |
1977年 | 31篇 |
1976年 | 17篇 |
1975年 | 26篇 |
1973年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Susan Niemantsverdriet Gerard D Majoor Cees P M van der Vleuten & Albert J J A Scherpbier 《Medical education》2004,38(7):749-757
OBJECTIVE: To explore learning outcomes from international traineeships for undergraduate medical students. METHODS: In-depth interviews were conducted with 24 undergraduate medical students at Maastricht University Medical School, The Netherlands. The 24 subjects were selected by purposeful sampling. RESULTS: Students reported meaningful learning outcomes in 6 domains: medical knowledge; skills; international health care organisation; international medical education; society and culture, and personal growth. DISCUSSION: International traineeships appear to provide good opportunities for students to meet the requirements of globalisation as well as some of the generic objectives of undergraduate medical education. The tentative findings of this study need to be confirmed by further studies. 相似文献
102.
103.
104.
105.
OBJECTIVE: Hpr6 (heme-1 domain protein/human progesterone receptor) is one of a family of proteins that are implicated in progesterone metabolism, resistance to genotoxic agents and steroid biosynthesis. Because these processes are frequently misregulated in tumors, we have examined the expression of Hpr6 in a group of clinical tumor samples and cancer cell lines. METHODS: Hpr6 expression was analyzed by Western blot in extracts from breast, cervix, colon and thyroid cell lines and in nonmalignant and adjacent tumor tissue from breast, colon and thyroid. Hpr6 localization was determined by immunofluorescence. RESULTS: Hpr6 expression is significantly elevated in breast tumors in comparison with matched nonmalignant tissue and demonstrated limited overexpression in colon and thyroid tumors. Hpr6 is strongly expressed in a panel of tumor cell lines originating from breast, thyroid and colon. Hpr6 localizes to the perinuclear region of the cell, consistent with a role in cell detoxification, signaling and/or sterol synthesis. CONCLUSIONS: Hpr6 homologues regulate cytochrome P450 proteins implicated in hormone, steroid and xenobiotic chemical metabolism. These are the first studies linking Hpr6 expression to cancer progression and cellular survival. Our results suggest that Hpr6 is an important marker for cancer progression and a potential anticancer therapeutic target. 相似文献
106.
107.
Ted A. Skolarus MD MPH Andrew M.D. Wolf MD Nicole L. Erb BA Durado D. Brooks MD MPH Brian M. Rivers PhD MPH Willie Underwood III MD MPH MSci Andrew L. Salner MD Michael J. Zelefsky MD Jeanny B. Aragon‐Ching MD Susan F. Slovin MD PhD Daniela A. Wittmann PhD MSW CST Michael A. Hoyt PhD Victoria J. Sinibaldi CRNP Gerald Chodak MD Mandi L. Pratt‐Chapman MA Rebecca L. Cowens‐Alvarado MPH 《CA: a cancer journal for clinicians》2014,64(4):225-249
Answer questions and earn CME/CNE Prostate cancer survivors approach 2.8 million in number and represent 1 in 5 of all cancer survivors in the United States. While guidelines exist for timely treatment and surveillance for recurrent disease, there is limited availability of guidelines that facilitate the provision of posttreatment clinical follow‐up care to address the myriad of long‐term and late effects that survivors may face. Based on recommendations set forth by a National Cancer Survivorship Resource Center expert panel, the American Cancer Society developed clinical follow‐up care guidelines to facilitate the provision of posttreatment care by primary care clinicians. These guidelines were developed using a combined approach of evidence synthesis and expert consensus. Existing guidelines for health promotion, surveillance, and screening for second primary cancers were referenced when available. To promote comprehensive follow‐up care and optimal health and quality of life for the posttreatment survivor, the guidelines address health promotion, surveillance for prostate cancer recurrence, screening for second primary cancers, long‐term and late effects assessment and management, psychosocial issues, and care coordination among the oncology team, primary care clinicians, and nononcology specialists. A key challenge to the development of these guidelines was the limited availability of published evidence for management of prostate cancer survivors after treatment. Much of the evidence relies on studies with small sample sizes and retrospective analyses of facility‐specific and population databases. CA Cancer J Clin 2014;64:225–249. © 2014 American Cancer Society . 相似文献
108.
澳大利亚的急救医疗体系在过去的30年经历了本质性的转变,包括院前急救的发展,院内急诊科的发展,以及急诊专科医师和急救师作为新的职业的发展.这一本质性的转变在其他很多国家也同时存在,并缘于卫生体系提供高质量的急救医疗服务的义务和不断增加的职业责任. 相似文献
109.
The practice of fasting recently has been purported to have clinical benefits, particularly as an intervention against obesity and its related pathologies. Although a number of different temporal dietary restriction strategies have been employed in practice, they are generally classified under the umbrella term “intermittent fasting” (IF). IF can be stratified into two main categories: (1) intra-weekly fasting (alternate-day fasting/ADF, twice-weekly fasting/TWF) and (2) intra-daily fasting (early time-restricted eating/eTRE and delayed time-restricted eating/dTRE). A growing body of evidence indicates that IF is a viable alternative to daily caloric restriction (DCR), showing effectiveness as a weight loss intervention. This paper narratively reviews the literature on the effects of various commonly used IF strategies on body weight and body composition when compared to traditional DCR approaches, and draws conclusions for their practical application. A specific focus is provided as to the use of IF in combination with regimented exercise programs and the associated effects on fat mass and lean mass. 相似文献
110.
Wei Xiao Longyi Du Linli Cai Tiwei Miao Bing Mao Fuqiang Wen Peter Gerard Gibson Deying Gong Yan Zeng Mei Kang Xinmiao Du Junyan Qu Yan Wang Xuemei Liu Ruizhi Feng Juanjuan Fu 《中华医学杂志(英文版)》2022,135(13):1545
Background:Although existing mycological tests (bronchoalveolar lavage [BAL] galactomannan [GM], serum GM, serum (1,3)-β-D-glucan [BDG], and fungal culture) are widely used for diagnosing invasive pulmonary aspergillosis (IPA) in non-hematological patients with respiratory diseases, their clinical utility in this large population is actually unclear. We aimed to resolve this clinical uncertainty by evaluating the diagnostic accuracy and utility of existing tests and explore the efficacy of novel sputum-based Aspergillus assays.Methods:Existing tests were assessed in a prospective and consecutive cohort of patients with respiratory diseases in West China Hospital between 2016 and 2019 while novel sputum assays (especially sputum GM and Aspergillus-specific lateral-flow device [LFD]) in a case-controlled subcohort. IPA was defined according to the modified European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria. Sensitivity and specificity were computed for each test and receiver operating characteristic (ROC) curve analysis was performed.Results:The entire cohort included 3530 admissions (proven/probable IPA = 66, no IPA = 3464) and the subcohort included 127 admissions (proven/probable IPA = 38, no IPA = 89). Sensitivity of BAL GM (≥1.0 optical density index [ODI]: 86% [24/28]) was substantially higher than that of serum GM (≥0.5 ODI: 38% [39/102]) (χ2 = 19.83, P < 0.001), serum BDG (≥70 pg/mL: 33% [31/95]) (χ2 = 24.65, P < 0.001), and fungal culture (33% [84/253]) (χ2 = 29.38, P < 0.001). Specificity varied between BAL GM (≥1.0 ODI: 94% [377/402]), serum GM (≥0.5 ODI: 95% [2130/2248]), BDG (89% [1878/2106]), and culture (98% [4936/5055]). Sputum GM (≥2.0 ODI) had similar sensitivity (84% [32/38]) (Fisher''s exact P = 1.000) to and slightly lower specificity (87% [77/89]) (χ2 = 5.52, P = 0.019) than BAL GM (≥1.0 ODI). Area under the ROC curve values were comparable between sputum GM (0.883 [0.812–0.953]) and BAL GM (0.901 [0.824–0.977]) (P = 0.734). Sputum LFD had similar specificity (91% [81/89]) (χ2 = 0.89, P = 0.345) to and lower sensitivity (63% [24/38]) (χ2 = 4.14, P = 0.042) than BAL GM (≥1.0 ODI), but significantly higher sensitivity than serum GM (≥0.5 ODI) (χ2 = 6.95, P = 0.008), BDG (χ2 = 10.43, P = 0.001), and fungal culture (χ2 = 12.70, P < 0.001).Conclusions:Serum GM, serum BDG, and fungal culture lack sufficient sensitivity for diagnosing IPA in respiratory patients. Sputum GM and LFD assays hold promise as rapid, sensitive, and non-invasive alternatives to the BAL GM test. 相似文献